Thirty Madison Vaults to Unicorn Status, Raises $140 Million
- Health-care startup’s revenue has been surging, CEO says
- Firm seeks to expand in the U.S. and, eventually, abroad
This article is for subscribers only.
Thirty Madison, a health-care startup that specializes in treating chronic conditions, has raised $140 million in funding, valuing the company at more than $1 billion and granting it so-called unicorn status.
HealthQuest Capital led the funding round, which included participation by Mousse Partners and Bracket Capital, as well existing backers Polaris Partners, Johnson & Johnson Innovation - JJDC Inc., Greycroft and Northzone.